Literature DB >> 8498489

G protein coupling of human platelet V1 vascular vasopressin receptors.

M Thibonnier1, T Goraya, L Berti-Mattera.   

Abstract

We used several approaches to identify the G protein coupled to V1 vascular arginine vasopressin (AVP) receptors of human platelets. In purified platelet membranes, high-affinity specific binding of [3H]AVP but not that of the V1 vascular antagonist [3H]d(CH2)5Tyr(Me)AVP was modulated by guanosine 5'-O-(3-thiotriphosphate) or sodium fluoride both in the presence and absence of MgCl2. AVP failed to modify the [alpha-32P]GTP labeling pattern or the cytosolic translocation of the 24- to 27-kDa GTP-binding proteins. AVP-stimulated GTPase activity of platelet membranes was blocked by antibodies specific for the COOH-terminal of the Gq alpha protein. AVP increased labeling of a 42-kDa platelet membrane protein by the photoreactive GTP analogue [alpha-32P]azidoanilido GTP. Immunoblotting of platelet proteins with various G protein-specific antibodies revealed that the 42-kDa protein labeled with [alpha-32P]azidoanilido GTP was immunoblotted only by antibodies specific for the alpha-subunit of GQ-11. Thus V1 vascular AVP receptors of human platelets are coupled in a divalent cation-dependent manner to a G protein belonging to the Gq-11 family.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8498489     DOI: 10.1152/ajpcell.1993.264.5.C1336

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

Review 1.  Genetics of aggression in voles.

Authors:  Kyle L Gobrogge; Zuoxin W Wang
Journal:  Adv Genet       Date:  2011       Impact factor: 1.944

2.  Neurochemical Mediation of Affiliation and Aggression Associated With Pair-Bonding.

Authors:  Kyle L Gobrogge; Xixi Jia; Yan Liu; Zuoxin Wang
Journal:  Biol Psychiatry       Date:  2016-02-21       Impact factor: 13.382

3.  Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies.

Authors:  Alison C MacKinnon; Uzma Tufail-Hanif; Mark Wheatley; Adriano G Rossi; Christopher Haslett; Michael Seckl; Tariq Sethi
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.